Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)
China
· Delayed Price · Currency is CNY 3.100
-0.330 (-9.62%)
Apr 25, 2025, 10:44 AM CST
SHA:600381 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 244.11 | 206.78 | 155.05 | 123.89 | 121.81 | 228.35 | Upgrade
|
| Other Revenue | 7.09 | 7.09 | 5.13 | 3.88 | 2.46 | 5.4 | Upgrade
|
| Revenue | 251.2 | 213.88 | 160.18 | 127.76 | 124.27 | 233.75 | Upgrade
|
| Revenue Growth (YoY) | 30.67% | 33.52% | 25.37% | 2.81% | -46.84% | -29.81% | Upgrade
|
| Cost of Revenue | 147.09 | 84.6 | 138.5 | 147.78 | 118.82 | 168.98 | Upgrade
|
| Gross Profit | 104.11 | 129.28 | 21.68 | -20.02 | 5.45 | 64.77 | Upgrade
|
| Selling, General & Admin | 214.91 | 224.04 | 188.41 | 118.56 | 112.64 | 106.62 | Upgrade
|
| Research & Development | 14.52 | 11.64 | 11.38 | 9.54 | 12.3 | 4.5 | Upgrade
|
| Other Operating Expenses | 2.58 | 3.69 | 2.93 | 3.19 | 1.57 | 1.93 | Upgrade
|
| Operating Expenses | 242.61 | 249.09 | 229.43 | 189.87 | 145.16 | 122.63 | Upgrade
|
| Operating Income | -138.5 | -119.81 | -207.75 | -209.89 | -139.72 | -57.86 | Upgrade
|
| Interest Expense | -0.84 | -0.91 | -0.09 | -0.05 | - | - | Upgrade
|
| Interest & Investment Income | 1.18 | 1.36 | 0.5 | 0.17 | 0.11 | 40.6 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.13 | -0.13 | -0.88 | 1.33 | -1.76 | 0.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.14 | -0.31 | -0.52 | 5.79 | -6.91 | -0.26 | Upgrade
|
| EBT Excluding Unusual Items | -140.43 | -119.82 | -208.74 | -202.64 | -148.28 | -16.82 | Upgrade
|
| Gain (Loss) on Sale of Investments | -139.78 | -139.81 | -46.96 | -51.13 | -139.88 | 1.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | 0.02 | -0.02 | -2.15 | 0.02 | Upgrade
|
| Asset Writedown | 0.08 | -0.03 | -40.68 | - | -25.43 | - | Upgrade
|
| Legal Settlements | - | - | - | -0.02 | -0.02 | -0.42 | Upgrade
|
| Other Unusual Items | -0.63 | -0.63 | 1.09 | 1.35 | 0.72 | 13.71 | Upgrade
|
| Pretax Income | -280.77 | -260.28 | -295.27 | -252.46 | -315.04 | -1.72 | Upgrade
|
| Income Tax Expense | 5.52 | 5.93 | -7.72 | -3.84 | 4.51 | -7.53 | Upgrade
|
| Earnings From Continuing Operations | -286.28 | -266.21 | -287.55 | -248.61 | -319.54 | 5.81 | Upgrade
|
| Minority Interest in Earnings | -1.7 | -1.65 | 0 | - | - | - | Upgrade
|
| Net Income | -287.99 | -267.87 | -287.55 | -248.61 | -319.54 | 5.81 | Upgrade
|
| Net Income to Common | -287.99 | -267.87 | -287.55 | -248.61 | -319.54 | 5.81 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -91.52% | Upgrade
|
| Shares Outstanding (Basic) | 580 | 582 | 587 | 592 | 592 | 581 | Upgrade
|
| Shares Outstanding (Diluted) | 580 | 582 | 587 | 592 | 592 | 581 | Upgrade
|
| Shares Change (YoY) | -0.71% | -0.77% | -0.86% | 0.03% | 1.89% | 1.82% | Upgrade
|
| EPS (Basic) | -0.50 | -0.46 | -0.49 | -0.42 | -0.54 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.50 | -0.46 | -0.49 | -0.42 | -0.54 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | - | -91.67% | Upgrade
|
| Free Cash Flow | 28.26 | 10.39 | -32.64 | -185.73 | -275.59 | -241.59 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.02 | -0.06 | -0.31 | -0.47 | -0.42 | Upgrade
|
| Gross Margin | 41.44% | 60.44% | 13.53% | -15.67% | 4.38% | 27.71% | Upgrade
|
| Operating Margin | -55.14% | -56.02% | -129.70% | -164.28% | -112.43% | -24.75% | Upgrade
|
| Profit Margin | -114.64% | -125.24% | -179.52% | -194.59% | -257.14% | 2.48% | Upgrade
|
| Free Cash Flow Margin | 11.25% | 4.86% | -20.38% | -145.37% | -221.77% | -103.35% | Upgrade
|
| EBITDA | -133.12 | -99.28 | -167.01 | -168.29 | -98.2 | -17.55 | Upgrade
|
| EBITDA Margin | -52.99% | -46.42% | -104.27% | -131.72% | -79.03% | -7.51% | Upgrade
|
| D&A For EBITDA | 5.39 | 20.54 | 40.74 | 41.59 | 41.51 | 40.31 | Upgrade
|
| EBIT | -138.5 | -119.81 | -207.75 | -209.89 | -139.72 | -57.86 | Upgrade
|
| EBIT Margin | -55.14% | -56.02% | -129.70% | -164.28% | -112.43% | -24.75% | Upgrade
|
| Revenue as Reported | 251.2 | 213.88 | 160.18 | 127.76 | 124.27 | 233.75 | Upgrade
|
| Advertising Expenses | - | - | - | 24.65 | 21.12 | 12.78 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.